Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
J Virol ; 94(21)2020 10 14.
Article in English | MEDLINE | ID: mdl-32817219

ABSTRACT

Adeno-associated viruses (AAVs) are dependoparvoviruses that have proven useful for therapeutic gene transfer; however, our understanding of host factors that influence AAV trafficking and transduction is still evolving. Here, we investigated the role of cellular calcium in the AAV infectious pathway. First, we demonstrated a critical role for the host Golgi compartment-resident ATP-powered calcium pump (secretory pathway calcium ATPase 1 [SPCA1]) encoded by the ATP2C1 gene in AAV infection. CRISPR-based knockout (KO) of ATP2C1 decreases transduction by different AAV serotypes. ATP2C1 KO does not appear to inhibit AAV binding, cellular uptake, or nuclear entry; however, capsids within ATP2C1 KO cells demonstrate dispersed and punctate trafficking distinct from the perinuclear, trans-Golgi pattern observed in normal cells. In addition, we observed a defect in the ability of AAV capsids to undergo conformational changes and support efficient vector genome transcription in ATP2C1 KO cells. The calcium chelator BAPTA-AM, which reduces cytosolic calcium, rescues the defective ATP2C1 KO phenotype and AAV transduction in vitro Conversely, the calcium ionophore ionomycin, which disrupts calcium gradients, blocks AAV transduction. Further, we demonstrated that modulating calcium in the murine brain using BAPTA-AM augments AAV gene expression in vivo Taking these data together, we postulate that the maintenance of an intracellular calcium gradient by the calcium ATPase and processing within the Golgi compartment are essential for priming the capsid to support efficient AAV genome transcription.IMPORTANCE Adeno-associated viruses (AAVs) have proven to be effective gene transfer vectors. However, our understanding of how the host cell environment influences AAV transduction is still evolving. In the present study, we investigated the role of ATP2C1, which encodes a membrane calcium transport pump, SPCA1, essential for maintaining cellular calcium homeostasis on AAV transduction. Our results indicate that cellular calcium is essential for efficient intracellular trafficking and conformational changes in the AAV capsid that support efficient genome transcription. Further, we show that pharmacological modulation of cellular calcium levels can potentially be applied to improve the AAV gene transfer efficiency.


Subject(s)
Calcium-Transporting ATPases/genetics , Calcium/metabolism , Dependovirus/genetics , Genetic Vectors/metabolism , Golgi Apparatus/metabolism , Animals , Animals, Newborn , Biological Transport/drug effects , Brain/drug effects , Brain/metabolism , CRISPR-Cas Systems , Calcium-Transporting ATPases/deficiency , Cell Line, Tumor , Chelating Agents/pharmacology , Dependovirus/drug effects , Dependovirus/metabolism , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Gene Deletion , Genetic Vectors/chemistry , Golgi Apparatus/drug effects , Golgi Apparatus/virology , HEK293 Cells , Hepatocytes/drug effects , Hepatocytes/metabolism , Hepatocytes/virology , Humans , Injections, Intraventricular , Ionomycin/pharmacology , Lentivirus/genetics , Lentivirus/metabolism , Mice , Mice, Inbred C57BL , Stereotaxic Techniques , Transduction, Genetic , Vesiculovirus/genetics , Vesiculovirus/metabolism
2.
J Virol ; 94(1)2019 12 12.
Article in English | MEDLINE | ID: mdl-31597780

ABSTRACT

Recombination is one of the driving forces of viral evolution. RNA recombination events among similar RNA viruses are frequent, although RNA recombination could also take place among unrelated viruses. In this paper, we have established efficient interviral recombination systems based on yeast and plants. We show that diverse RNA viruses, including the plant viruses tomato bushy stunt virus, carnation Italian ringspot virus, and turnip crinkle virus-associated RNA; the insect plus-strand RNA [(+)RNA] viruses Flock House virus and Nodamura virus; and the double-stranded L-A virus of yeast, are involved in interviral recombination events. Most interviral recombinants are minus-strand recombinant RNAs, and the junction sites are not randomly distributed, but there are certain hot spot regions. Formation of interviral recombinants in yeast and plants is accelerated by depletion of the cellular SERCA-like Pmr1 ATPase-driven Ca2+/Mn2+ pump, regulating intracellular Ca2+ and Mn2+ influx into the Golgi apparatus from the cytosol. The interviral recombinants are generated by a template-switching mechanism during RNA replication by the viral replicase. Replication studies revealed that a group of interviral recombinants is replication competent in cell-free extracts, in yeast, and in the plant Nicotiana benthamiana We propose that there are major differences among the viral replicases to generate and maintain interviral recombinants. Altogether, the obtained data promote the model that host factors greatly contribute to the formation of recombinants among related and unrelated viruses. This is the first time that a host factor's role in affecting interviral recombination is established.IMPORTANCE Viruses with RNA genomes are abundant, and their genomic sequences show astonishing variation. Genetic recombination in RNA viruses is a major force behind their rapid evolution, enhanced pathogenesis, and adaptation to their hosts. We utilized a previously identified intracellular Ca2+/Mn2+ pump-deficient yeast to search for interviral recombinants. Noninfectious viral replication systems were used to avoid generating unwanted infectious interviral recombinants. Altogether, interviral RNA recombinants were observed between plant and insect viruses, and between a fungal double-stranded RNA (dsRNA) virus and an insect virus, in the yeast host. In addition, interviral recombinants between two plant virus replicon RNAs were identified in N. benthamiana plants, in which the intracellular Ca2+/Mn2+ pump was depleted. These findings underline the crucial role of the host in promoting RNA recombination among unrelated viruses.


Subject(s)
Calcium-Transporting ATPases/genetics , Carmovirus/genetics , Molecular Chaperones/genetics , Nodaviridae/genetics , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae/genetics , Tombusvirus/genetics , Agrobacterium tumefaciens/genetics , Agrobacterium tumefaciens/metabolism , Calcium/metabolism , Calcium-Transporting ATPases/deficiency , Carmovirus/metabolism , Cations, Divalent , Cell-Free System/chemistry , Cell-Free System/metabolism , Cell-Free System/virology , Ion Transport , Manganese/metabolism , Nodaviridae/metabolism , RNA, Viral/genetics , RNA, Viral/metabolism , RNA-Dependent RNA Polymerase/genetics , RNA-Dependent RNA Polymerase/metabolism , Recombination, Genetic , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae/virology , Nicotiana/genetics , Nicotiana/metabolism , Nicotiana/virology , Tombusvirus/metabolism , Viral Proteins/genetics , Viral Proteins/metabolism , Virus Replication
3.
J Cell Physiol ; 233(1): 11-22, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28247940

ABSTRACT

Reduced sperm motility (asthenospermia) and resulting infertility arise from deletion of the Plasma Membrane Ca2+ -ATPase 4 (Pmca4) gene which encodes the highly conserved Ca2+ efflux pump, PMCA4. This is the major Ca2+ clearance protein in murine sperm. Since the mechanism underlying asthenospermia in PMCA4's absence or reduced activity is unknown, we investigated if sperm PMCA4 negatively regulates nitric oxide synthases (NOSs) and when absent NO, peroxynitrite, and oxidative stress levels are increased. Using co-immunoprecipitation (Co-IP) and Fluorescence Resonance Energy Transfer (FRET), we show an association of PMCA4 with the NOSs in elevated cytosolic [Ca2+ ] in capacitated and Ca2+ ionophore-treated sperm and with neuronal (nNOS) at basal [Ca2+ ] (ucapacitated sperm). FRET efficiencies for PMCA4-eNOS were 35% and 23% in capacitated and uncapacitated sperm, significantly (p < 0.01) different, with the molecules being <10 nm apart. For PMCA4-nNOS, this interaction was seen only for capacitated sperm where FRET efficiency was 24%, significantly (p < 0.05) higher than in uncapacitated sperm (6%). PMCA4 and the NOSs were identified as interacting partners in a quaternary complex that includes Caveolin1, which co-immunoprecipitated with eNOS in a Ca2+ -dependent manner. In Pmca4-/- sperm NOS activity was elevated twofold in capacitated/uncapacitated sperm (vs. wild-type), accompanied by a twofold increase in peroxynitrite levels and significantly (p < 0.001) increased numbers of apoptotic germ cells. The data support a quaternary complex model in which PMCA4 co-ordinates Ca2+ and NO signaling to maintain motility, with increased NO levels resulting in asthenospermia in Pmca4-/- males. They suggest the involvement of PMCA4 mutations in human asthenospermia, with diagnostic relevance.


Subject(s)
Asthenozoospermia/enzymology , Calcium Signaling , Calcium-Transporting ATPases/metabolism , Cell Membrane/enzymology , Nitric Oxide/metabolism , Sperm Motility , Spermatozoa/enzymology , Animals , Apoptosis , Asthenozoospermia/genetics , Asthenozoospermia/pathology , Asthenozoospermia/physiopathology , Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Caveolin 1/metabolism , Fertility , Fluorescence Resonance Energy Transfer , Genetic Predisposition to Disease , Male , Mice, Inbred C57BL , Mice, Inbred ICR , Mice, Knockout , Multienzyme Complexes , Nitric Oxide Synthase Type I/metabolism , Nitric Oxide Synthase Type III/metabolism , Oxidative Stress , Peroxynitrous Acid/metabolism , Phenotype , Spermatozoa/pathology
4.
Biochim Biophys Acta ; 1863(11): 2650-2657, 2016 11.
Article in English | MEDLINE | ID: mdl-27523793

ABSTRACT

BACKGROUND: Hailey-Hailey disease (HHD), also known as familial benign chronic pemphigus, is a rare, chronic and recurrent blistering disorder, histologically characterized by suprabasal acantholysis. HHD has been linked to mutations in ATP2C1, the gene encoding the human adenosine triphosphate (ATP)-powered calcium channel pump. METHODS: In this work, the genetically tractable yeast Kluyveromyces lactis has been used to study the molecular basis of Hailey-Hailey disease. The K. lactis strain depleted of PMR1, the orthologue of the human ATP2C1 gene, was used to screen a Madin-Darby canine kidney (MDCK) cDNA library to identify genetic interactors able to suppress the oxidative stress occurring in those cells. RESULTS: We have identified the Glutathione S-transferase Ï´-subunit (GST), an important detoxifying enzyme, which restores many of the defects associated with the pmr1Δmutant. GST overexpression in those cells suppressed the sensitivity to calcium chelating agents and partially re-established calcium (Ca2+) homeostasis by decreasing the high cytosolic Ca2+ levels in pmr1Δstrain. Moreover, we found that in the K. lactis mutant the mitochondrial dysfunction was suppressed by GST overexpression independently from calcineurin. In agreement with yeast results, a decreased expression of the human GST counterpart (GSTT1/M1) was observed in lesion-derived keratinocytes from HHD patients. CONCLUSIONS: These data highlighted the Glutathione S-transferase as a candidate gene associated with Hailey-Hailey disease. GENERAL SIGNIFICANCE: Kluyveromyces lactis can be considered a good model to study the molecular basis of this pathology.


Subject(s)
Fungal Proteins/metabolism , Glutathione Transferase/metabolism , Keratinocytes/enzymology , Kluyveromyces/enzymology , Pemphigus, Benign Familial/enzymology , Animals , Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Dogs , Fungal Proteins/genetics , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Fungal , Genetic Association Studies , Genetic Predisposition to Disease , Glutathione Transferase/genetics , Hydrogen Peroxide/pharmacology , Keratinocytes/pathology , Kluyveromyces/drug effects , Kluyveromyces/genetics , Kluyveromyces/growth & development , Madin Darby Canine Kidney Cells , Oxidation-Reduction , Oxidative Stress , Pemphigus, Benign Familial/genetics , Pemphigus, Benign Familial/pathology , Phenotype
5.
Nat Commun ; 7: 11074, 2016 Mar 29.
Article in English | MEDLINE | ID: mdl-27020607

ABSTRACT

The heart responds to pathological overload through myocyte hypertrophy. Here we show that this response is regulated by cardiac fibroblasts via a paracrine mechanism involving plasma membrane calcium ATPase 4 (PMCA4). Pmca4 deletion in mice, both systemically and specifically in fibroblasts, reduces the hypertrophic response to pressure overload; however, knocking out Pmca4 specifically in cardiomyocytes does not produce this effect. Mechanistically, cardiac fibroblasts lacking PMCA4 produce higher levels of secreted frizzled related protein 2 (sFRP2), which inhibits the hypertrophic response in neighbouring cardiomyocytes. Furthermore, we show that treatment with the PMCA4 inhibitor aurintricarboxylic acid (ATA) inhibits and reverses cardiac hypertrophy induced by pressure overload in mice. Our results reveal that PMCA4 regulates the development of cardiac hypertrophy and provide proof of principle for a therapeutic approach to treat this condition.


Subject(s)
Calcium-Transporting ATPases/metabolism , Cardiomegaly/pathology , Cell Membrane/enzymology , Fibroblasts/metabolism , Myocardium/pathology , Myocytes, Cardiac/pathology , Signal Transduction , Animals , Animals, Newborn , Aorta/pathology , Aurintricarboxylic Acid/pharmacology , Calcium-Transporting ATPases/antagonists & inhibitors , Calcium-Transporting ATPases/deficiency , Cardiomegaly/complications , Cell Membrane/drug effects , Constriction, Pathologic , Culture Media, Conditioned/pharmacology , Disease Models, Animal , Fibroblasts/drug effects , Gene Deletion , Membrane Proteins/metabolism , Mice, Knockout , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Pressure , Signal Transduction/drug effects
6.
Arterioscler Thromb Vasc Biol ; 34(10): 2310-20, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25147342

ABSTRACT

OBJECTIVE: Vascular endothelial growth factor (VEGF) has been identified as a crucial regulator of physiological and pathological angiogenesis. Among the intracellular signaling pathways triggered by VEGF, activation of the calcineurin/nuclear factor of activated T cells (NFAT) signaling axis has emerged as a critical mediator of angiogenic processes. We and others previously reported a novel role for the plasma membrane calcium ATPase (PMCA) as an endogenous inhibitor of the calcineurin/NFAT pathway, via interaction with calcineurin, in cardiomyocytes and breast cancer cells. However, the functional significance of the PMCA/calcineurin interaction in endothelial pathophysiology has not been addressed thus far. APPROACH AND RESULTS: Using in vitro and in vivo assays, we here demonstrate that the interaction between PMCA4 and calcineurin in VEGF-stimulated endothelial cells leads to downregulation of the calcineurin/NFAT pathway and to a significant reduction in the subsequent expression of the NFAT-dependent, VEGF-activated, proangiogenic genes RCAN1.4 and Cox-2. PMCA4-dependent inhibition of calcineurin signaling translates into a reduction in endothelial cell motility and blood vessel formation that ultimately impairs in vivo angiogenesis by VEGF. CONCLUSIONS: Given the importance of the calcineurin/NFAT pathway in the regulation of pathological angiogenesis, targeted modulation of PMCA4 functionality might open novel therapeutic avenues to promote or attenuate new vessel formation in diseases that occur with angiogenesis.


Subject(s)
Angiogenesis Inducing Agents/pharmacology , Calcineurin/metabolism , Calcium-Transporting ATPases/metabolism , Endothelial Cells/drug effects , Muscle, Skeletal/blood supply , Neovascularization, Physiologic/drug effects , Plasma Membrane Calcium-Transporting ATPases/metabolism , Vascular Endothelial Growth Factor A/pharmacology , Animals , Calcium-Binding Proteins , Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Cell Movement , Cell Proliferation , Cyclooxygenase 2/metabolism , DNA-Binding Proteins , Disease Models, Animal , Endothelial Cells/enzymology , HEK293 Cells , Hindlimb , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/enzymology , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Ischemia/enzymology , Ischemia/physiopathology , Mice , Mice, Knockout , Muscle Proteins/metabolism , NFATC Transcription Factors/genetics , NFATC Transcription Factors/metabolism , Plasma Membrane Calcium-Transporting ATPases/genetics , RNA Interference , Signal Transduction , Time Factors , Transfection
7.
Biochim Biophys Acta ; 1843(10): 2315-21, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24583118

ABSTRACT

Cross-complementation studies offer the possibility to overcome limitations imposed by the inherent complexity of multicellular organisms in the study of human diseases, by taking advantage of simpler model organisms like the budding yeast Saccharomyces cerevisiae. This review deals with, (1) the use of S. cerevisiae as a model organism to study human diseases, (2) yeast-based screening systems for the detection of disease modifiers, (3) Hailey-Hailey as an example of a calcium-related disease, and (4) the presentation of a yeast-based model to search for chemical modifiers of Hailey-Hailey disease. The preliminary experimental data presented and discussed here show that it is possible to use yeast as a model system for Hailey-Hailey disease and suggest that in all likelihood, yeast has the potential to reveal candidate drugs for the treatment of this disorder. This article is part of a Special Issue entitled: Calcium signaling in health and disease. Guest Editors: Geert Bultynck, Jacques Haiech, Claus W. Heizmann, Joachim Krebs, and Marc Moreau.


Subject(s)
Calcium-Transporting ATPases/genetics , Calcium/metabolism , Models, Biological , Molecular Chaperones/genetics , Pemphigus, Benign Familial/genetics , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae/genetics , Administration, Cutaneous , Calcium Signaling , Calcium-Transporting ATPases/deficiency , Dermatologic Agents/pharmacology , Dihydroxycholecalciferols/pharmacology , Gene Expression , Humans , Keratinocytes/drug effects , Keratinocytes/metabolism , Keratinocytes/pathology , Mutation , Pemphigus, Benign Familial/drug therapy , Pemphigus, Benign Familial/metabolism , Pemphigus, Benign Familial/pathology , Saccharomyces cerevisiae/metabolism , Skin/drug effects , Skin/metabolism , Skin/pathology
8.
Cell Death Differ ; 20(3): 465-77, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23154387

ABSTRACT

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons, which arises from a yet elusive concurrence between genetic and environmental factors. The protein α-synuclein (αSyn), the principle toxic effector in PD, has been shown to interfere with neuronal Ca(2+) fluxes, arguing for an involvement of deregulated Ca(2+) homeostasis in this neuronal demise. Here, we identify the Golgi-resident Ca(2+)/Mn(2+) ATPase PMR1 (plasma membrane-related Ca(2+)-ATPase 1) as a phylogenetically conserved mediator of αSyn-driven changes in Ca(2+) homeostasis and cytotoxicity. Expression of αSyn in yeast resulted in elevated cytosolic Ca(2+) levels and increased cell death, both of which could be inhibited by deletion of PMR1. Accordingly, absence of PMR1 prevented αSyn-induced loss of dopaminergic neurons in nematodes and flies. In addition, αSyn failed to compromise locomotion and survival of flies when PMR1 was absent. In conclusion, the αSyn-driven rise of cytosolic Ca(2+) levels is pivotal for its cytotoxicity and requires PMR1.


Subject(s)
Calcium-Transporting ATPases/metabolism , Calcium/metabolism , Models, Biological , Saccharomyces cerevisiae Proteins/metabolism , alpha-Synuclein/metabolism , Acetylcysteine/pharmacology , Animals , Apoptosis , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Humans , Manganese/metabolism , Molecular Chaperones , Oxidative Stress , Parkinson Disease/metabolism , Parkinson Disease/pathology , Phosphorylation , Promoter Regions, Genetic , RNA Interference , RNA, Small Interfering/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , alpha-Synuclein/genetics , alpha-Synuclein/toxicity
9.
J Neurosci ; 29(39): 12174-82, 2009 Sep 30.
Article in English | MEDLINE | ID: mdl-19793975

ABSTRACT

Neural cell differentiation involves a complex regulatory signal transduction network in which Ca(2+) ions and the secretory pathway play pivotal roles. The secretory pathway Ca(2+)-ATPase isoform 1 (SPCA1) is found in the Golgi apparatus where it is actively involved in the transport of Ca(2+) or Mn(2+) from the cytosol to the Golgi lumen. Its expression during brain development in different types of neurons has been documented recently, which raises the possibility that SPCA1 contributes to neuronal differentiation. In the present study, we investigated the potential impact of SPCA1 on neuronal polarization both in a cell line and in primary neuronal culture. In N2a neuroblastoma cells, SPCA1 was immunocytochemically localized in the juxtanuclear Golgi. Knockdown of SPCA1 by RNA interference markedly delayed the differentiation in these cells. The cells retarded in differentiation showed increased numbers of neurites of reduced length compared with control cells. Ca(2+) imaging assays showed that the lack of SPCA1 impaired Golgi Ca(2+) homeostasis and resulted in disturbed trafficking of different classes of proteins including normally Golgi-localized cameleon GT-YC3.3, bearing a Golgi-specific galactosyltransferase N terminus, and a normally plasma membrane-targeted, glycosyl phosphatidyl inositol-anchored cyan fluorescent protein construct. Also in hippocampal primary neurons, which showed a differential distribution of SPCA1 expression in Golgi stacks depending on differentiation stage, partial silencing of SPCA1 resulted in delayed differentiation, whereas total suppression drastically affected the cell survival. The disturbed overall cellular Ca(2+) homeostasis and/or the altered targeting of organellar proteins under conditions of SPCA1 knockdown highlight the importance of SPCA1 function for normal neural differentiation.


Subject(s)
Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Calcium/metabolism , Cell Polarity/genetics , Gene Silencing , Golgi Apparatus/genetics , Homeostasis/genetics , Secretory Pathway/genetics , Animals , Calcium/physiology , Calcium-Transporting ATPases/metabolism , Cell Differentiation/genetics , Cells, Cultured , Gene Knockdown Techniques/methods , Isoenzymes/deficiency , Isoenzymes/genetics , Isoenzymes/metabolism , Mice , Neurons/cytology , Neurons/metabolism , Neurons/physiology
10.
Nan Fang Yi Ke Da Xue Xue Bao ; 29(8): 1565-7, 2009 Aug.
Article in Chinese | MEDLINE | ID: mdl-19726293

ABSTRACT

OBJECTIVE: To assess the effect of RNA interference-mediated gene silencing of plasma membrane-related Ca(2+)-ATPase-1 (PMR1) gene on the insulin secretion in islet beta cells NIT-1 in vitro. METHODS: A small interfering RNA duplex (siPMR1) corresponding to the nucleotides 337-357 of mouse PMR1 cDNA was introduced into NIT-1 cells via liposomes. The gene silencing effect was assessed by RT-PCR, and the total insulin level in the transfected cells was measured by radioimmunoassay. RESULTS: Transfection with siPMR1 resulted in obviously reduced PMR1 expression and increased insulin secretion in NIT-1 cells. CONCLUSION: The synthesized siPMR1 can significantly silence the expression of PMR1 and promote the secretion of insulin in the islet cells in vitro, which shed light on further studies of RNAi-based therapy of diabetes.


Subject(s)
Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Insulin-Secreting Cells/metabolism , Insulin/metabolism , RNA Interference , Animals , Cell Line , Gene Expression Regulation , Insulin Secretion , Mice , RNA, Messenger/genetics , RNA, Messenger/metabolism
11.
J Biol Chem ; 282(36): 26517-27, 2007 Sep 07.
Article in English | MEDLINE | ID: mdl-17597066

ABSTRACT

Loss of one copy of the human ATP2C1 gene, encoding SPCA1 (secretory pathway Ca(2+)-ATPase isoform 1), causes Hailey-Hailey disease, a skin disorder. We performed targeted mutagenesis of the Atp2c1 gene in mice to analyze the functions of this Golgi membrane Ca(2+) pump. Breeding of heterozygous mutants yielded a normal Mendelian ratio among embryos on gestation day 9.5; however, null mutant (Spca1(-/-)) embryos exhibited growth retardation and did not survive beyond gestation day 10.5. Spca1(-/-) embryos had an open rostral neural tube, but hematopoiesis and cardiovascular development were ostensibly normal. Golgi membranes of Spca1(-/-) embryos were dilated, had fewer stacked leaflets, and were expanded in amount, consistent with increased Golgi biogenesis. The number of Golgi-associated vesicles was also increased, and rough endoplasmic reticulum had fewer ribosomes. Coated pits, junctional complexes, desmosomes, and basement membranes appeared normal in mutant embryos, indicating that processing and trafficking of proteins in the secretory pathway was not massively impaired. However, apoptosis was increased, possibly the result of secretory pathway stress, and a large increase in cytoplasmic lipid was observed in mutant embryos, consistent with impaired handling of lipid by the Golgi. Adult heterozygous mice appeared normal and exhibited no evidence of Hailey-Hailey disease; however, aged heterozygotes had an increased incidence of squamous cell tumors of keratinized epithelial cells of the skin and esophagus. These data show that loss of the Golgi Ca(2+) pump causes Golgi stress, expansion of the Golgi, increased apoptosis, and embryonic lethality and demonstrates that SPCA1 haploinsufficiency causes a genetic predisposition to cancer.


Subject(s)
Calcium-Transporting ATPases/deficiency , Carcinoma, Squamous Cell/metabolism , Embryo Loss/metabolism , Esophageal Neoplasms/metabolism , Golgi Apparatus/metabolism , Loss of Heterozygosity , Skin Neoplasms/metabolism , Aging/genetics , Aging/metabolism , Aging/pathology , Animals , Apoptosis/genetics , Basement Membrane/metabolism , Basement Membrane/ultrastructure , Calcium-Transporting ATPases/metabolism , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cardiovascular System/embryology , Coated Pits, Cell-Membrane/genetics , Coated Pits, Cell-Membrane/metabolism , Coated Pits, Cell-Membrane/ultrastructure , Desmosomes/genetics , Desmosomes/metabolism , Desmosomes/ultrastructure , Embryo Loss/genetics , Embryo Loss/pathology , Endoplasmic Reticulum, Rough/genetics , Endoplasmic Reticulum, Rough/metabolism , Endoplasmic Reticulum, Rough/ultrastructure , Esophageal Neoplasms/genetics , Esophageal Neoplasms/pathology , Female , Genetic Predisposition to Disease , Golgi Apparatus/ultrastructure , Hematopoiesis/genetics , Heterozygote , Homozygote , Humans , Inbreeding , Loss of Heterozygosity/genetics , Male , Mice , Mice, Knockout , Neural Tube Defects/embryology , Neural Tube Defects/metabolism , Neural Tube Defects/pathology , Pemphigus, Benign Familial/genetics , Pemphigus, Benign Familial/metabolism , Pemphigus, Benign Familial/pathology , Pregnancy , Protein Transport/genetics , Ribosomes/metabolism , Secretory Vesicles/genetics , Secretory Vesicles/metabolism , Secretory Vesicles/ultrastructure , Skin Neoplasms/genetics , Skin Neoplasms/pathology
12.
J Mol Cell Cardiol ; 41(2): 308-17, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16814319

ABSTRACT

Abnormal Ca(2+) cycling in the failing heart might be corrected by enhancing the activity of the cardiac Ca(2+) pump, the sarco(endo)plasmic reticulum Ca(2+)-ATPase 2a (SERCA2a) isoform. This can be obtained by increasing the pump's affinity for Ca(2+) by suppressing phospholamban (PLB) activity, the in vivo inhibitor of SERCA2a. In SKO mice, gene-targeted replacement of SERCA2a by SERCA2b, a pump with a higher Ca(2+) affinity, results in cardiac hypertrophy and dysfunction. The stronger PLB inhibition on cardiac morphology and performance observed in SKO was investigated here in DKO mice, which were obtained by crossing SKO with PLB(-/-) mice. The affinity for Ca(2+) of SERCA2 was found to be further increased in these DKO mice. Relative to wild-type and SKO mice, DKO mice were much less spontaneously active and showed a reduced life span. The DKO mice also displayed a severe cardiac phenotype characterized by a more pronounced concentric hypertrophy, diastolic dysfunction and increased ventricular stiffness. Strikingly, beta-adrenergic or forced exercise stress induced acute heart failure and death in DKO mice. Therefore, the increased PLB inhibition represents a compensation for the imposed high Ca(2+)-affinity of SERCA2b in the SKO heart. Limiting SERCA2's affinity for Ca(2+) is physiologically important for normal cardiac function. An improved Ca(2+) transport in the sarcoplasmic reticulum may correct Ca(2+) mishandling in heart failure, but a SERCA pump with a much higher Ca(2+) affinity may be detrimental.


Subject(s)
Calcium-Binding Proteins/metabolism , Calcium-Transporting ATPases/metabolism , Calcium/metabolism , Cardiomegaly/metabolism , Longevity , Stress, Physiological , Animals , Calcium-Binding Proteins/deficiency , Calcium-Transporting ATPases/deficiency , Cardiomegaly/genetics , Cardiomegaly/pathology , Crosses, Genetic , Heart Failure/genetics , Heart Failure/metabolism , Heart Failure/pathology , Ion Transport/genetics , Longevity/genetics , Mice , Mice, Knockout , Physical Conditioning, Animal/adverse effects , Sarcoplasmic Reticulum/genetics , Sarcoplasmic Reticulum/metabolism , Sarcoplasmic Reticulum/pathology , Sarcoplasmic Reticulum Calcium-Transporting ATPases , Substrate Specificity/genetics
13.
J Biol Chem ; 281(33): 23341-8, 2006 Aug 18.
Article in English | MEDLINE | ID: mdl-16735509

ABSTRACT

The main role of the plasma membrane Ca2+/calmodulin-dependent ATPase (PMCA) is in the removal of Ca2+ from the cytosol. Recently, we and others have suggested a new function for PMCA as a modulator of signal transduction pathways. This paper shows the physical interaction between PMCA (isoforms 1 and 4) and alpha-1 syntrophin and proposes a ternary complex of interaction between endogenous PMCA, alpha-1 syntrophin, and NOS-1 in cardiac cells. We have identified that the linker region between the pleckstrin homology 2 (PH2) and the syntrophin unique (SU) domains, corresponding to amino acids 399-447 of alpha-1 syntrophin, is crucial for interaction with PMCA1 and -4. The PH2 and the SU domains alone failed to interact with PMCA. The functionality of the interaction was demonstrated by investigating the inhibition of neuronal nitric-oxide synthase-1 (NOS-1); PMCA is a negative regulator of NOS-1-dependent NO production, and overexpression of alpha-1 syntrophin and PMCA4 resulted in strongly increased inhibition of NO production. Analysis of the expression levels of alpha-1 syntrophin protein in the heart, skeletal muscle, brain, uterus, kidney, or liver of PMCA4-/- mice, did not reveal any differences when compared with those found in the same tissues of wild-type mice. These results suggest that PMCA4 is tethered to the syntrophin complex as a regulator of NOS-1, but its absence does not cause collapse of the complex, contrary to what has been reported for other proteins within the complex, such as dystrophin. In conclusion, the present data demonstrate for the first time the localization of PMCA1b and -4b to the syntrophin.dystrophin complex in the heart and provide a specific molecular mechanism of interaction as well as functionality.


Subject(s)
Calcium-Binding Proteins/chemistry , Calcium-Transporting ATPases/chemistry , Cation Transport Proteins/chemistry , Membrane Proteins/chemistry , Muscle Proteins/chemistry , Muscle, Skeletal/enzymology , Myocardium/chemistry , Nitric Oxide Synthase Type I/chemistry , Sarcolemma/enzymology , Animals , Calcium-Binding Proteins/metabolism , Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Calcium-Transporting ATPases/metabolism , Cation Transport Proteins/deficiency , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Cell Line , Dystrophin/physiology , Humans , Membrane Proteins/metabolism , Mice , Mice, Knockout , Muscle Proteins/metabolism , Muscle, Skeletal/metabolism , Myocardium/enzymology , Myocardium/metabolism , Nitric Oxide Synthase Type I/metabolism , Plasma Membrane Calcium-Transporting ATPases , Protein Binding , Protein Structure, Tertiary , Sarcolemma/metabolism , Signal Transduction/physiology
14.
Proteomics ; 6(15): 4321-34, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16800037

ABSTRACT

Recent proteomic applications have demonstrated their potential for revealing the molecular mechanisms underlying neurodegeneration. The present study quantifies cerebellar protein changes in mice that are deficient in plasma membrane calcium ATPase 2 (PMCA2), an essential neuronal pump that extrudes calcium from cells and is abundantly expressed in Purkinje neurons. PMCA2-null mice display motor dyscoordination and unsteady gait deficits observed in neurological diseases such as multiple sclerosis and ataxia. We optimized an amine-specific isobaric tags (iTRAQ)-based shotgun proteomics workflow for this study. This workflow took consideration of analytical variance as a function of ion signal intensity and employed biological repeats to aid noise reduction. Even with stringent protein identification criteria, we could reliably quantify nearly 1000 proteins, including many neuronal proteins that are important for synaptic function. We identified 21 proteins that were differentially expressed in PMCA2-null mice. These proteins are involved in calcium homeostasis, cell structure and chromosome organization. Our findings shed light on the molecular changes that underlie the neurological deficits observed in PMCA2-null mice. The optimized workflow presented here will be valuable for others who plan to implement the iTRAQ method.


Subject(s)
Amines/chemistry , Cerebellar Diseases/metabolism , Proteins/metabolism , Proteomics/methods , Animals , Blotting, Western , Calbindins , Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Calcium-Transporting ATPases/metabolism , Cation Transport Proteins/deficiency , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Cerebellar Diseases/genetics , Cerebellum/metabolism , Cerebellum/pathology , Chromatography, Ion Exchange/methods , Computational Biology , Disease Models, Animal , Electrophoresis, Gel, Two-Dimensional , Mice , Mice, Inbred C57BL , Mice, Knockout , Plasma Membrane Calcium-Transporting ATPases , Proteins/analysis , Reproducibility of Results , S100 Calcium Binding Protein G/analysis , S100 Calcium Binding Protein G/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
15.
Actas Dermosifiliogr ; 97(2): 139-41, 2006 Mar.
Article in Spanish | MEDLINE | ID: mdl-16595119

ABSTRACT

Darier disease is a genodermatosis with a pattern of autosomal dominant inheritance, which occasionally presents by following a linear or segmental pattern. We present the case of a 22-year-old woman who had presented for three years with small, linearly distributed, yellowish-brown papules on the right lower extremity, with no other skin, mucous membrane or appendage involvement. She had no personal or family history of any interest. Histologically, suprabasal acantholysis and abundant dyskeratotic cells were seen. All of this data led to the diagnosis of linear Darier disease.


Subject(s)
Darier Disease/pathology , Adult , Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/genetics , Chromosomes, Human, Pair 12/genetics , Darier Disease/diagnosis , Darier Disease/genetics , Female , Humans , Leg , Mosaicism , Sarcoplasmic Reticulum Calcium-Transporting ATPases
16.
Neuroscience ; 139(4): 1507-24, 2006.
Article in English | MEDLINE | ID: mdl-16529873

ABSTRACT

The neocortex of congenitally deaf mice was examined using electrophysiological recording techniques combined with cortical myeloarchitecture. Our results indicate that relative activity patterns across sensory systems during development contribute to modality assignment of cortical fields as well as the size of cortical fields. In congenitally deaf mice, "auditory cortex" contained neurons that responded to somatosensory, visual, or both somatosensory and visual stimulation; the primary visual area contained a larger proportion of neurons that responded to somatosensory stimulation than in normal animals, and the primary visual area had significantly increased in size. Thus, cortical architecture and functional specification were de-correlated. When results are considered in the light of molecular studies and studies in which peripheral activity is altered in development, it becomes clear that similar types of changes to the neocortex, such as alterations in cortical field size, can be achieved in more than one way in the developing and evolving neocortex.


Subject(s)
Brain Mapping , Cerebral Cortex/pathology , Deafness , Neuronal Plasticity/physiology , Neurons, Afferent/physiology , 3,4-Dihydroxyphenylacetic Acid/metabolism , Acoustic Stimulation/methods , Animals , Calcium-Transporting ATPases/deficiency , Cation Transport Proteins/deficiency , Deafness/genetics , Deafness/pathology , Deafness/physiopathology , Disease Models, Animal , Dose-Response Relationship, Radiation , Evoked Potentials, Auditory, Brain Stem/physiology , Mice , Mice, Knockout , Otoacoustic Emissions, Spontaneous/physiology , Plasma Membrane Calcium-Transporting ATPases , Sodium-Potassium-Chloride Symporters/deficiency , Solute Carrier Family 12, Member 2
17.
Heart ; 92(1): 105-9, 2006 Jan.
Article in English | MEDLINE | ID: mdl-15845614

ABSTRACT

OBJECTIVE: To verify whether a deficiency in the cardiac sarcoplasmic reticulum pump SERCA2a causes cardiac dysfunction in humans. DESIGN: Cardiac performance was measured in a serendipitous human model of primary SERCA2a deficiency, Darier's disease, an autosomal dominant skin disorder caused by mutations inactivating one copy of the ATP2A2 gene, which encodes SERCA2a. METHODS: Systolic and diastolic function and contractility were assessed by echocardiography at rest and during exercise in patients with Darier's disease with known mutations. Fourteen patients with Darier's disease were compared with 14 normal controls and six patients with dilated cardiomyopathy with stable heart failure. RESULTS: Resting systolic and diastolic function was normal in patients with Darier's disease and in controls. The increase in systolic function during exercise was not different between patients with Darier's disease and normal controls; neither was there a difference in contractility. As expected, patients with dilated cardiomyopathy had impaired diastolic and systolic function with depressed contractility at rest and during exercise. CONCLUSION: Contrary to expectations, heterozygous disruption of SERCA2a is not associated with the impairment of cardiac performance in humans. Attempts to increase SERCA2a levels in heart failure, although showing promise in rodent studies, may not be addressing a critical causal pathway in humans.


Subject(s)
Calcium-Transporting ATPases/genetics , Cardiomyopathy, Dilated/genetics , Darier Disease/genetics , Heart Failure/genetics , Heterozygote , Calcium-Transporting ATPases/deficiency , Case-Control Studies , Exercise Tolerance , Female , Genetic Therapy/methods , Heart Failure/therapy , Humans , Male , Middle Aged , Mutation/genetics , Sarcoplasmic Reticulum Calcium-Transporting ATPases
18.
FEMS Microbiol Lett ; 251(2): 333-9, 2005 Oct 15.
Article in English | MEDLINE | ID: mdl-16143464

ABSTRACT

PMR1, the Ca2+/Mn2+ ATPase of the secretory pathway in Saccharomyces cerevisiae was the first member of the secretory pathway Ca2+ ATPases (SPCA) to be characterized. In the past few years, pmr1Delta yeast have received more attention due to the recognition that the human homologue of this protein, hSPCA1 is defective in chronic benign pemphigus or Hailey-Hailey disease (HHD). Recent publications have described pmr1Delta S. cerevisiae as a useful model organism for studying the molecular pathology of HHD. Some observations indicated that the high Ca2+ sensitive phenotype of PMR1 defective yeast strains may be the most relevant in this respect. Here we show that the total cellular calcium response of a pmr1Delta S. cerevisiae upon extracellular Ca2+ challenge is decreased compared to the wild type strain similarly as observed in keratinocytes. Additionally, the novel magnesium sensitivity of PMR1 defective yeast is revealed, which appears to be a result of competition for uptake between Ca2+ and Mg2+ at the plasma membrane level. Our findings indicate that extracellular Ca2+ and Mg2+ competitively influence the intracellular Ca2+ homeostasis of S. cerevisiae. These observations may further our understanding of HHD.


Subject(s)
Calcium-Transporting ATPases/deficiency , Calcium/pharmacology , Magnesium/pharmacology , Saccharomyces cerevisiae/drug effects , Calcium-Transporting ATPases/genetics , Calcium-Transporting ATPases/metabolism , Pemphigus, Benign Familial , Saccharomyces cerevisiae/growth & development
19.
Dtsch Med Wochenschr ; 130(12): 726-30, 2005 Mar 24.
Article in German | MEDLINE | ID: mdl-15776359

ABSTRACT

In elderly patients, an inadequately treated high blood pressure often leads to hypertrophied cardiomyocytes with various defects in gene expression. Due to a decreased expression of the transcription factor PPARalpha, fatty acid oxidation is reduced. If it can be compensated by an increased glucose oxidation, it has been considered as a favorable process. Nonetheless, reduced PPARalpha influences ensue involving e. g. anti-inflammatory mechanisms. The question arises thus whether drugs can normalize reduced PPARalpha effects without increasing fatty acid oxidation. As lead compound of these "fatty acid oxidation inhibitors with PPARalpha activation", the carnitine palmitoyltransferase-1 inhibitor etomoxir was characterized. An increased expression and activity of the Ca (2+) pump of sarcoplasmic reticulum, a faster relaxation and a slowed progression of heart failure was observed in animal experiments. It should, therefore, be examined whether the impaired function of pressure overloaded hypertrophied cardiomyocytes of particularly elderly patients should be a therapeutic target before progression of heart failure, neuroendocrine activation and symptoms such as shortness of breath occur.


Subject(s)
Cardiomegaly/drug therapy , Carnitine O-Palmitoyltransferase/antagonists & inhibitors , Energy Metabolism/genetics , Epoxy Compounds/therapeutic use , Fatty Acids/metabolism , Heart Failure/drug therapy , Hypolipidemic Agents/therapeutic use , Myocardium/metabolism , PPAR alpha/genetics , Animals , Blood Glucose/metabolism , Calcium-Transporting ATPases/deficiency , Calcium-Transporting ATPases/physiology , Cardiomegaly/genetics , Cardiomegaly/physiopathology , Energy Metabolism/drug effects , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Heart Failure/genetics , Heart Failure/physiopathology , Hemodynamics/genetics , Hemodynamics/physiology , Humans , Myocardial Contraction/genetics , Myocardial Contraction/physiology , Oxidation-Reduction/drug effects , PPAR alpha/physiology , Sarcoplasmic Reticulum Calcium-Transporting ATPases
20.
J Biol Chem ; 280(10): 9467-73, 2005 Mar 11.
Article in English | MEDLINE | ID: mdl-15623514

ABSTRACT

Relatively few clues have been uncovered to elucidate the cell biological role(s) of mammalian ATP2C1 encoding an inwardly directed secretory pathway Ca2+/Mn2+ pump that is ubiquitously expressed. Deficiency of ATP2C1 results in a human disease (Hailey-Hailey), which primarily affects keratinocytes. ATP2C1-encoded protein is detected in the Golgi complex in a calcium-dependent manner. A small interfering RNA causes knockdown of ATP2C1 expression, resulting in defects in both post-translational processing of wild-type thyroglobulin (a secretory glycoprotein) as well as endoplasmic reticulum-associated protein degradation of mutant thyroglobulin, whereas degradation of a nonglycosylated misfolded secretory protein substrate appears unaffected. Knockdown of ATP2C1 is not associated with elevated steady state levels of ER chaperone proteins, nor does it block cellular activation of either the PERK, ATF6, or Ire1/XBP1 portions of the ER stress response. However, deficiency of ATP2C1 renders cells hypersensitive to ER stress. These data point to the important contributions of the Golgi-localized ATP2C1 protein in homeostatic maintenance throughout the secretory pathway.


Subject(s)
Calcium-Transporting ATPases/genetics , Endoplasmic Reticulum/genetics , Pemphigus, Benign Familial/genetics , Animals , Calcium-Transporting ATPases/deficiency , Cell Line , Cell Line, Tumor , Codon/genetics , DNA Primers , Endoplasmic Reticulum/physiology , Gene Deletion , Golgi Apparatus/genetics , Golgi Apparatus/physiology , Humans , Keratinocytes/physiology , Oxidative Stress , Recombinant Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Saccharomyces cerevisiae/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...